Krystal Biotech, Inc.
KRYS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $389M | $291M | +33.9% |
| Operating income | $161M | $65.8M | +145% |
| Net income | $205M | $89.2M | +130% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $127M | $97.8M | +30.2% |
| Operating income | $71.1M | $41.4M | +71.7% |
| Net income | $63.1M | $79.4M | −20.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Krystal Biotech's revenue in FY2025?
- $389M in FY2025 (Fiscal year ended Dec 31, 2025), +33.9% vs $291M a year earlier, per its 10-K filed Feb 2026.
- Was Krystal Biotech profitable in FY2025?
- Yes: net income was $205M and operating income $161M in FY2025.
- What was Krystal Biotech's revenue in Q3 2026?
- $127M (+30.2% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.